"In several clinical studies it has been proven that our Procedicus simulators, such as MIST and VIST, improved performance in the operating room. With the unique procedure rehearsal capability and fidelity, demonstrated at the Euro-PCR, we can now advance the field of endovascular simulation to the next generation: Patient specific training and pre procedure planning and rehearsal", stated Mr. Jonas Ohlsson, President of Mentice Corporation.
The live case transmission was scheduled for Wednesday, May 26, during the focus session "Carotid Stenting: Do Emboli Matter?" Dr. Lukas van Dijk, radiologist, and Dr. Johanna Hendriks, vascular surgeon, at the Erasmus Medical Center in Rotterdam, The Netherlands, performed both the virtual and actual procedures. Dr. Marc van Sambeek, vascular surgeon at the same hospital, moderated the focus session.
"Virtual Procedure Rehearsal brings several advantages, including anticipation of complications, better informed selection of tools and techniques to be used, and reduction of procedure time", stated Dr. Van Sambeek. "We believe these advances will result in higher procedure success rates and in cost reductions."
Due to its revolutionary impact on training for interventional procedures, Mentice training simulators were integrated into the core curriculum of Euro-PCR. "The advantages of this innovative training tool are comparable to those of flight simulator training", stated Professor Marco of Clinique Pasteur in Toulouse and course director of Euro-PCR. "With this tool, a physician can become proficient at the procedure in a very short timeframe without the pressures of actual surgery. It is clear that in the future this type of training will become mandatory in the education of physicians."
The annual Paris Course on Revascularization, held May 25-28 in Paris, is focused on education and training of physicians who treat patients with cardiovascular diseases. Advanced education techniques and programmes are of particular interest and value at the well-attended event.
Mentice provides turnkey solutions such as Procedicus VIST, including hardware, software and technical support, from entry-level skills acquisition to high-fidelity procedural training. With the Procedicus products, Mentice focuses on the following minimally invasive surgery areas: endovascular intervention, laparoscopy and arthroscopy.
More than 6000 participants have attended Guidant's Institute for Therapy Advancement in Brussels, Belgium, where physicians are provided with discussion forums and hands-on experience moderated by a faculty of independent clinical experts. The institute's programmes aim to advance the standard of care and improve patient outcomes. Guidant opened a second Institute in Tokyo, Japan, and is constructing a third in St. Paul, Minnesota, USA.
Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to millions of cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of 12.000 employees, develops, manufactures and markets a road array of products and services that enable less invasive care for some of life's most threatening medical conditions. More news on Guidant is available in the VMW December 2003 article Guidant broadens Advanced Patient Management initiative with CardioMEMS investment.